MAPT and Alzheimer disease: However, before the diagnostic utility of CSF tau and Aβ42 concentration for diagnosis of AD can be established, it is crucial to assess whether the effect sizes of the published studies reported in the last fifteen years show consistent trends in their levels or not in AD cases as compared to controls.